Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.

Autor: Dave F; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Vaghela P; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Heath B; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Dunster Z; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Dubinina E; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Thakker D; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Mann K; Scancell Ltd., Bellhouse Building, Oxford Science Park, Oxford, United Kingdom., Chadwick J; Scancell Ltd., Bellhouse Building, Oxford Science Park, Oxford, United Kingdom., Cane G; Scancell Ltd., Bellhouse Building, Oxford Science Park, Oxford, United Kingdom., Kaira BG; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Mohammed OJ; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Choudhury R; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Paston S; Scancell Ltd., Bellhouse Building, Oxford Science Park, Oxford, United Kingdom., Parsons T; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Vankemmelbeke M; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Durrant L; Scancell Ltd., Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Nov 04; Vol. 23 (11), pp. 1626-1638.